XML 67 R53.htm IDEA: XBRL DOCUMENT v3.21.2
AQUISITIONS - Resolution Bioscience Acquisition (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 15, 2021
Aug. 23, 2019
Oct. 31, 2021
Oct. 31, 2020
Business Acquisition [Line Items]        
Fair Value of Contingent Consideration     $ 89 $ 0
Goodwill arising from acquisitions     365 0
Additions and adjustments to other intangibles       $ 0
Diagnostics and Genomics        
Business Acquisition [Line Items]        
Goodwill arising from acquisitions     365  
Significant Unobservable Inputs (Level 3) | Fair Value, Recurring        
Business Acquisition [Line Items]        
Fair Value of Contingent Consideration $ 110   $ 89  
Resolution Bioscience, Inc.        
Business Acquisition [Line Items]        
Purchase price for acquisition 561      
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $ 145      
Contingent consideration arrangements does not exceed     3 years 2 months 12 days  
Additions and adjustments to other intangibles     $ 343  
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life     11 years  
Deferred Tax Liability     $ 59  
Net Tangible assets acquired     $ 22  
BioTek        
Business Acquisition [Line Items]        
Purchase price for acquisition   $ 1,170    
Goodwill arising from acquisitions   $ 483